Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | SI | P14410 | 1/20 | 0.54 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.54 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.48 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL7946812 | 1.00 | MGAM (0.54) | MGAMGAASIMGAM2DGKA | |
| Hexane SCHEMBL8710112 | 0.98 | MGAM (0.52) | MGAMGAASIMGAM2DGKA | |
| Heptane SCHEMBL200855 | 0.98 | DGKA (0.57) | MGAMGAASIMGAM2DGKA | |
| Tetradecane SCHEMBL9947966 | 0.98 | DGKA (0.57) | MGAMGAASIMGAM2DGKA | |
| Pentane SCHEMBL4415680 | 0.95 | GAA (0.54) | MGAMGAASIMGAM2DGKA | |
| Hexane SCHEMBL16566680 | 0.94 | DGKA (0.48) | MGAMGAASIMGAM2DGKA | |
| SCHEMBL936467 | 0.94 | DGKA (0.64) | DGKACYP1A2PAMLMNAKDM4E | |
| Hexane SCHEMBL5329217 | 0.92 | ALDH1A1 (0.54) | MGAMGAASIMGAM2DGKA | |
| Hexane SCHEMBL2346139 | 0.92 | ALDH1A1 (0.54) | MGAMGAASIMGAM2DGKA | |
| SCHEMBL6403 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114989185-B | Extraction and preparation method of stephanine | 四川健腾药业有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117915920-A | Use of terpenoids in the treatment or prevention of fibrotic diseases | 吉亚生技控股股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-116744953-A | Use of terpenoids in the treatment or prevention of fibrotic diseases | 吉亚生技控股股份有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116600822-A | Use of terpenoids in the treatment or prevention of fibrotic diseases | 吉亚生技控股股份有限公司 | 2023-08-15 | — | — | CN | claimed |
| US-20230201221-A1 | USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | Arjil Biotech Holding Company Limited (TW) | 2023-06-29 | — | — | US | claimed |
| US-20230190850-A1 | USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | Arjil Biotech Holding Company Limited (TW) | 2023-06-22 | — | — | US | claimed |
| CN-116068119-A | Detection method of kidney-tonifying essence-replenishing oral liquid | 九芝堂股份有限公司 | 2023-05-05 | — | — | CN | claimed |
| US-20230041859-A1 | USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | Arjil Biotech Holding Company Limited (TW) | 2023-02-09 | — | — | US | claimed |
| CN-111122735-B | Ligusticum wallichii medicine quality detection method | 贵州景峰注射剂有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-112684093-B | Quality detection method of eleven-prescription medicinal liquor | 广西中医药大学 | 2022-11-25 | — | — | CN | claimed |
| CN-101168009-B | Quality control method of macaque stone bovinebezoar powder | GUANGZHOU QIXING PHARMACY GROUP CO LTD | 2010-10-06 | — | — | CN | claimed |
| US-20100210869-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2010-08-19 | — | — | US | claimed |
| CN-101805352-A | Method for preparing eriocalyxin B | KUNMING INST BOTANY CN ACAD | 2010-08-18 | — | — | CN | claimed |
| CN-101584809-A | Medicine for treating cold-type yellow water disease and preparation and detection methods thereof | GANSU QIZHENG TIBETAN MEDICINE (CN) | 2009-11-25 | — | — | CN | claimed |
| CN-101168009-A | Quality control method of macaque stone bovinebezoar powder | GUANGZHOU QIXING PHARMACY GROU (CN) | 2008-04-30 | — | — | CN | claimed |
| CN-1325098-C | Traditional Chinese medicine composition for improving immunity and preparation method and quality control method thereof | WANG WEIMING (CN) | 2007-07-11 | — | — | CN | claimed |
| US-7119213-B2 | Pharmacologically active isolated or purified dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same | Kim, Jong Mun (KR) | 2006-10-10 | — | — | US | claimed |
| CN-1788775-A | Traditional Chinese medicine composition for improving immunity and preparation method and quality control method thereof | WANG WEIMING (CN) | 2006-06-21 | — | — | CN | claimed |
| CN-1247992-C | Method for drafting traditional Chinese medicinal spectrum by employing high-speed reverse-flow chromatogram | INST PROCESS ENG CAS (CN) | 2006-03-29 | — | — | CN | claimed |
| CN-1566942-A | Method for drafting traditional Chinese medicinal spectrum by employing high-speed reverse-flow chromatogram | INST PROCESS ENG CAS (CN) | 2005-01-19 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201221-A1 | USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | MMP1, SMAD3, COL1A1 | MGAM 2732/4885GAA 516/4885SI 1099/4885 |
| US-20230041859-A1 | USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | MMP1, SMAD3, COL1A1 | MGAM 2732/4885GAA 516/4885SI 1099/4885 |
| US-20100210869-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | BAX, API5, BCL2 | MGAM 3379/4885GAA 1854/4885SI 118/4885 |
| US-20230190850-A1 | USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | MMP1, COL1A1, SMAD3 | MGAM 3051/4885GAA 516/4885SI 1316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.